Abnormalities of the p53 MDM2 and DCC genes in human leiomyosarcomas

British Journal of Cancer

Volumn 69, Issue 6, 1994, Pages 1052-1058

  Patterson, H ^a   Gill, S ^a   Fisher, C ^b   Law, M G ^a   Jayatilake, H ^a   Fletcher, C D M ^c   Thomas, M ^b   Grimer, R ^d   Gusterson, B A ^a   Cooper, C S ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

^c St Thomas's Hospital   (United Kingdom)

^d ROYAL ORTHOPAEDIC HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MONOCLONAL ANTIBODY; PROTEIN P53;

ARTICLE; CANCER CELL CULTURE; CANCER GENETICS; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION REGULATION; GENE REARRANGEMENT; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEIOMYOSARCOMA; MALE; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN CONTENT; SOUTHERN BLOTTING; TUMOR SUPPRESSOR GENE;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BASE SEQUENCE; DNA MUTATIONAL ANALYSIS; DNA PRIMERS; DOXORUBICIN; EXONS; FOLLOW-UP STUDIES; GENE DELETION; GENES, DCC; GENES, P53; HUMAN; IFOSFAMIDE; IMMUNOHISTOCHEMISTRY; LEIOMYOSARCOMA; MALE; MESNA; MIDDLE AGE; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; NEOPLASM STAGING; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM (GENETICS); PROTEIN P53; SUPPORT, NON-U.S. GOV'T; SURVIVAL ANALYSIS;

EID: 0028334197     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.1994.207     Document Type: Article

References (41)

1. ALLRED, D.C., CLARK, G.M., ELLEDGE, R., FUQUA, S A W., BROWN, R.W., CHAMNESS, G.C., OSBORNE, C.K. & MCGUIRE, W.L. (1993). Association of p53 protein expression with tumour cell proliferation rate and clinical outcome in node-negative breast cancer. J. Natl Cancer Inst., 85, 200-206.
2. BAKER, S.J., FEARON, S.E., NIGRO, J.M., HAMILTON, S.R., PREISINGER, A C., JESSUP, J.M., VAN TUINEN, P., LEDBETTER, D.H., BARKER, D.F., NAKAMURA, Y., WHITE, R. & VOGELSTEIN, B. (1989) Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science, 244, 217-221.
3. BAKER, S.J., PREISINGER, A C., JESSUP, J.M., PARASKEVA, C., MARKOWITZ, S., WILLSON, J.K.V., HAMILTON, S. & VOGELSTEIN, B., (1990). p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumourigenesis. Cancer Res., 50, 7717-7722.
4. BARTEK, J., IGGO, R., GANNON, J. & LANE, D.P. (1990). Genetic and immunochemical analysis of mutant p53 in human breast cancer cell lines. Oncogene, 5, 893-899.
5. CHEN, P.-L., CHEN, Y., BOOKSTEIN, R. & LEE, W.-H. (1990). Genetic mechanisms of tumour suppression by the human p53 gene. Science, 250, 1576.
6. CHURCH, G.M. & GILBERT, W. (1984). Genomic sequencing. Proc. Natl Acad. Sci. USA, 81, 1991-1995.
7. CONDIE, A., EELES, R., BORRESEN, A.L., COLES, C., COOPER, C.S & PROSSER, J. (1993). Detection of point mutations in the p53 gene: comparison of single-strand conformation polymorphism, constant denaturant gel electrophoresis, and hydroxylamine and osmium tetroxide techniques. Hum. Mutat., 2, 58-66.
8. DELEO, A.B., JAY, G., APPELLA, E., DUBOIS, G.C., LAW, L.W. & OLD, L.J. (1979). Detection of a transformation-related antigen in chemically induced sarcomas and other transformed cells of the mouse. Proc. Natl Acad. Sci. USA, 76, 2420-2424.
9. ELIYAHU, D., RAZ, A., GRUSS, P., GIVOL, D. & OREN, M. (1984). Participation of p53 cellular tumour antigen in transformation of normal embryonic cells. Nature, 312, 646-649.
10. FAKHARZADEH, S.S., TRUSKO, S.P. & GEORGE, D. (1991). Tumourigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumour cell line. EM BO J., 10, 1565-1569.
11. FAVALORO, J., TREISMAN, R. & KAMEN, R. (1980). Transcription maps of polyoma virus-specific RNA: Analysis by two-dimensional nuclease SI mapping. Methods Enzymol., 65, 718.
12. FEARON, E.R., CHO, K.R., NIGRO, J.M., KERN, S.E., SIMONS, J.W., RUPPERT, J.M., HAMILTON, S R., PREISINGER, A C., THOMAS, G., KINZLER, K.W. & VOGELSTEIN, B. (1990). Identification of a chromosome 18q gene that is altered in colorectal cancers. Science, 247, 49-56.
13. FEINBERG, A.P. & VOGELSTEIN, B. (1983). A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem., 132, 6-13.
14. FINLAY, C.A., HINDS, P.W., TAN, T. H., ELIYAHU, D., OREN, M. & LEVINE, A.J. (1988). Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life. Mol. Cell Biol., 8, 531-539.
15. GARVIN, A.J., STANLEY, W.S., BENNETT, D.D., SULLIVAN, J.L. & SENS, D.A. (1986). The in vitro growth, heterotransplantation and differentiation of a human rhabdomyosarcoma cell line. Am. J. Pathol., 125, 208-217.
16. GUSTERSON, B.A., ANBAZHAGEN, R., WARREN, W., MIDGELY, C., LANE, D.P., O’HARE, M., STAMPS, A., CARTER, R. & JAYATILAKE, H. (1991). Expression of p53 in premalignant and malignant squamous epithelium. Oncogene, 6, 1785-1789.
17. HINDS, P., FINLAY, C., & LEVINE, A.J. (1989). Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation. J. Virol., 63, 739-746.
18. HOLLSTEIN, M., SIDRANSKY, D., VOGELSTEIN, B. & HARRIS, C.C. (1991) 53 mutations in human cancers. Science, 253, 49-53.
19. JENKINS, J.R., RUDGE, K. & CURRIE, G.A. (1984). Cellular immortalisation by a cDNA clone encoding the transformation-associated phosphoprotein p53. Nature, 312, 651-654.
20. LANE, D.P. & CRAWFORD, L.V. (1979). T antigen is bound to a host protein in SV40-transformed cells. Nature, 278, 261-263.
21. LEVINE, A.J., MOMAND, J. & FINLAY, C.A. (1991). The p53 tumour suppressor gene. Nature, 351, 453-456.
22. MARLHENS, F., DELATTRE, O., BERNARD, A., OLSCHWANG, S., DUTRILLAUX, B. & THOMAS, G. (1987). RFLP identified by the anonymous DNA segment OL VII E10 at 18q21.3 (HGM no. D18S8). Nucleic Acids Res., 15, 1348.
23. MARTIN, H.M., FILIPE, M.I., MORRIS, R.W., LANE, D.P. & SILVESTRE, F. (1992). p53 expression and prognosis in gastric carcinoma. Int. J. Cancer, 50, 859-862.
24. MOMAND, J., ZAMBETT, G.P., OLSON, DC., GEORFE, D.L. & LEVINE, A.J. (1992). The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell, 69, 1237-1245.
25. MOWAT, M., CHENG, A., KIMURA, N., BERNSTEIN, A. & BENCHIMOL, S. (1985). Rearrangements of the cellular p53 gene in erythroleukaemia cells transformed by Friend virus. Nature, 314, 633-636.
26. NARAYANAN, R., LAWLOR, K.G., SCHAAPVELD, R.Q.J., CHO, K.R., VOGELSTEIN, B., BUIVINH TRAN, P., OSBORNE, M.P. & TELANG, N.T. (1992). Antisense RNA to the putative tumour-suppressor gene DCC transforms Rat-1 fibroblasts. Oncogene, 7, 553-561.
27. NOONAN, K.E. & RONINSON, I.B. (1988). mRNA phenotyping by enzymatic amplification of randomly primed cDNA. Nucleic Acids Res., 16, 10366.
28. OLINER, J.D., KINZLER, K.W., MELTZER, P.S., GEORGE, D.L. & VOGELSTEIN, B. (1992). Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature, 358, 80-83.
29. ORITA, M., SUZUKI, Y., SEKIYA, T. & HAYASHI, K. (1989). Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics, 5, 874.
30. PROSSER, J., THOMPSON, A.M., CRANSTON, G. & EVANS, H.J. (1990). Evidence that p53 behaves as a tumour suppressor gene in sporadic breast tumours. Oncogene, 5, 1573-1579.
31. RHIM, J.S., PARK, D.K., ARNSTEIN, P., HUEBNER, R.J., WEISBURGER, E.K. & NELSON-REES, W.A. (1975). Transformation of human cells in culture by N-methyl-N’-nitro-N-nitrosoguanidine. Nature, 256, 751-753.
32. RODRIGUES, N.R., ROWAN, A., SMITH, M.E.F., KERR, IB., BODMER, W.F., GANNON, J.V. & LANE, D.P. (1990). p53 mutations in colorectal cancer. Proc. Natl Acad. Sci. USA, 87, 7555-7559.
33. RUSSELL, W.O., COHEN, J., ENZINGER, F., HAJDU, S.I., HEISE, H., MARTIN, R.G., MEISSNER, W., MILLER, W.T., SCHMITZ, R.L. & SUIT, H.D. (1977). A clinical and pathological staging system for soft tissue sarcomas. Cancer, 40, 1562-1570.
34. SAIKI, R.K., GELFAND, D.H., STOFFEL, S., SCHARF, S.J., HIGUCHI, R., HORN, G.T., MULLIS, K.B. & ERLICH, H.A. (1988). Primer-detected enzymatic amplification of DNA with a thermostable DNA polymerase. Science, 239, 487-491.
35. SOUSSI, T., CARON DE FROMENTEL, C. & MAY, P. (1990). Structural aspects of the p53 protein in relation to gene evolution. Oncogene, 5, 945-952.
36. STEFFEN, D. & WEINBERG, R.A. (1978). The integrated genome of murine leukaemia virus. Cell, 15, 1003-1010.
37. STRATTON, M R., WILLIAMS, S., FISHER, C., BALL, A., WESTBURY, G., GUSTERSON, B.A., FLETCHER, C.D.M., KNIGHT, J.C., FUNG, Y.-K., REEVES, B.R. & COOPER, C.S. (1989). Structural alterations of the RBI gene in human soft tissue tumours. Br. J. Cancer, 60, 202-205.
38. STRATTON, M.R., MOSS, S., WARREN, W., PATTERSON, H., CLARK, J., FISHER, C., FLETCHER, C.D.M., BALL, A., THOMAS, M., GUSTERSON, B.A. & COOPER, C.S. (1990). Mutation of the p53 gene in human soft tissue sarcomas: association with abnormalities of the RBI gene. Oncogene, 5, 1297-1301.
39. TAKAHASHI, T., NAU, M.M., CHIBA, I., BIRRER, M.J., ROSENBERG, R.K., VINOCOUR, M., LEVITT, M., PASS, H., GAZDAR, A.F. & MINNA, J.D. (1989). p53: a target for genetic abnormalities in lung cancer. Science, 246, 491-494.
40. TAKAHASHI, T., SUZUKI, H., HIDA, T., SEKIDO, Y., ARIYOSHI, Y. & UEDA, R. (1991). The p53 gene is very frequently mutated in small-cell lung cancer with a distinct nucleotide substitution pattern. Oncogene, 6, 1775-1778.
41. VISAKORPI, T., KALLIONIEMI, O. P., HEIKKINEN, A., KOIVULA, T. & ISOLA, J. (1992). Small subgroup of aggressive, highly proliferative prostatic carcinomas defined by p53 accumulation. J. Natl Cancer Inst., 84, 883-887.